Infectious Diseases and Therapy

Search all Infectious Diseases and Therapy articles

Volume 11, Issue 2

April 2022

22 articles in this issue

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
Yara Ruiz Garcia
Véronique Abitbol
Lamine Soumahoro
Review Open access 30 September 2021 Pages: 639 - 655
Part of 1 collection:

Digital Features - Infectious Diseases
Correction to: A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine
Yara Ruiz Garcia
Véronique Abitbol
Lamine Soumahoro
Correction Open access 27 November 2021 Pages: 657 - 659
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Ashlan J. Kunz Coyne
Amer El Ghali
Michael J. Rybak
Review Open access 12 February 2022 Pages: 661 - 682
Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
Carmi Bartal
Kenneth V. I. Rolston
Lior Nesher
Review Open access 17 February 2022 Pages: 683 - 694
Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review
Rajamanthrilage Kasun Madusanka
Hermali Silva
Nadira D. Karunaweera
Review Open access 22 February 2022 Pages: 695 - 711
Coccidioidomycosis: A Contemporary Review
Nancy F. Crum
Review Open access 01 March 2022 Pages: 713 - 742
A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing
Marta Díaz-Navarro
Rama Hafian
María Guembe
Original Research Open access 16 January 2022 Pages: 743 - 755
GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
Iris De Ryck
Eleanna Sarakinou
Audino Podda
Original Research Open access 03 February 2022 Pages: 757 - 770
Association of Thiamine Use with Outcomes in Patients with Sepsis and Alcohol Use Disorder: An Analysis of the MIMIC-III Database
Chang Hu
Tong Wu
Jianguo Li
Original Research Open access 15 February 2022 Pages: 771 - 786
Machine Learning-Based COVID-19 Patients Triage Algorithm Using Patient-Generated Health Data from Nationwide Multicenter Database
Min Sue Park
Hyeontae Jo
Hyung Ju Hwang
Original Research Open access 16 February 2022 Pages: 787 - 805
Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled Trial
Sadhna Joglekar
Shivakumar S. Iyer
Shashank R. Joshi
Original Research Open access 18 February 2022 Pages: 807 - 826
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
Matteo Bassetti
Antonio Vena
from the Study Group for Infections in Critically Ill Patients (ESGCIP) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
Original Research Open access 19 February 2022 Pages: 827 - 840
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions
Stephen J. Balevic
Shruti M. Raja
Jeffrey T. Guptill
Original Research Open access 20 February 2022 Pages: 841 - 852
Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies
David L. Paterson
Masahiro Kinoshita
Simon Portsmouth
Original Research Open access 20 February 2022 Pages: 853 - 870
Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan
Wei-Chang Huang
Chih-Bin Lin
Chen-Yuan Chiang
Original Research Open access 07 March 2022 Pages: 871 - 885
Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study
Lakshmi Swaminathan
Scott Kaatz
Hallie C. Prescott
Original Research Open access 10 March 2022 Pages: 887 - 898
EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study
Ryan D. Kilpatrick
Olga Sánchez-Soliño
Gregory C. Gray
Brief Report Open access 02 February 2022 Pages: 899 - 911
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension
Robert S. Brown Jr.
Michelle A. Collins
Jordan J. Feld
Brief Report Open access 17 February 2022 Pages: 913 - 924
Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study”
Charles Phillipe de Lucena Alves
Marcelo Rodrigues dos Santos
Daisy Motta-Santos
Letter Open access 04 February 2022 Pages: 925 - 927
A Response to: Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study”
Ricardo Salgado-Aranda
Letter Open access 02 February 2022 Pages: 929 - 931
Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study
María Martínez-Rebollar
Lorena De La Mora
Montserrat Laguno
Correction Open access 16 February 2022 Pages: 933 - 933
Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study
Guanhao Zheng
Jianxin Zhang
Xiaolan Bian
Correction Open access 28 February 2022 Pages: 935 - 936

Volume 11, Issue 2

A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

Correction to: A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options

Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review

Coccidioidomycosis: A Contemporary Review

A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

Association of Thiamine Use with Outcomes in Patients with Sepsis and Alcohol Use Disorder: An Analysis of the MIMIC-III Database

Machine Learning-Based COVID-19 Patients Triage Algorithm Using Patient-Generated Health Data from Nationwide Multicenter Database

Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled Trial

Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions

Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies

Performance of Nucleic Acid Amplification Tests in Patients with Presumptive Pulmonary Tuberculosis in Taiwan

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study

Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension

Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study”

A Response to: Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study”

Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study

Correction to: Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study

Journal navigation